To complement the PSA test, another focus was to examine the diagnostic efficacy of Galectin-3 (Gal-3), a lectin-family oncogenic protein expressing in both primary and secondary lesions of prostate cancer. The gene discussed is LGALS3; the disease is prostate carcinoma.